Rita Lemming
About Rita Lemming
Rita Lemming is the Director of Clinical Operations at Fulcrum Therapeutics, where she has worked since 2023. She has extensive experience in clinical trial management, having held various roles at companies such as Loxo Oncology, Mersana Therapeutics, and Pharmacyclics.
Current Role at Fulcrum Therapeutics
Rita Lemming serves as the Director of Clinical Operations at Fulcrum Therapeutics. She has held this position since 2023, contributing to the company's clinical strategy and operations. Her role involves overseeing clinical trials and ensuring compliance with regulatory standards.
Previous Experience in Clinical Operations
Prior to her current role, Rita Lemming worked at several organizations in clinical operations. She was a Senior Clinical Trial Manager at Loxo Oncology at Lilly for eight months in 2020 to 2021. Additionally, she held positions at Mersana Therapeutics as Associate Director from 2022 to 2023 and at Sunesis Pharmaceuticals, Inc. as Clinical Trial Manager from 2019 to 2020.
Career Development at Pharmacyclics
Rita Lemming has extensive experience at Pharmacyclics, an AbbVie Company, where she worked in various roles from 2015 to 2019. She started as a Senior Clinical Trials Assistant, then progressed to Clinical Research Associate I, Clinical Research Associate II, and finally Senior Clinical Research Associate. This progression reflects her development in clinical research and trial management.
Educational Background in Psychobiology
Rita Lemming studied Psychobiology at Binghamton University, where she earned her Bachelor of Science degree. Her studies spanned from 2005 to 2007, providing her with a foundation in the biological and psychological aspects of human behavior, which is relevant to her work in clinical operations.